⌘K

Home/Filings/4/0001209191-22-008774

4//SEC Filing

FRAKES JAMES B 4

Accession 0001209191-22-008774

CIK 0000882291other

View on SEC.gov Company Profile

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 1:57 PM ET

Size

5.5 KB

Accession

0001209191-22-008774

Insider Transaction Report

Form 4

Period: 2022-02-10

AETHLON MEDICAL INCAEMD

Chief Financial Officer

Transactions

Award
Employee Stock Option (Right to Buy)
2022-02-10+100,200→ 100,200 total
Exercise: $1.41Exp: 2032-02-09→ Common Stock (100,200 underlying)

Footnotes (1)

[F1]25% of the shares subject to the stock option shall vest and become exercisable on February 10, 2023, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

AETHLON MEDICAL INC

CIK 0000882291

Entity typeother

Related Parties

1

filerCIK 0001185553

Filing Metadata

Form type: 4
Filed: Feb 10, 7:00 PM ET
Accepted: Feb 11, 1:57 PM ET
Size: 5.5 KB

View on SEC.gov